Group 1: Tesla - Tesla's stock rose by 3.56%, reaching a nearly one-year high with a trading volume of $54.109 billion [1][7] - The company is piloting a Robotaxi service in Austin without a safety driver, confirming the shift towards autonomous driving [1][8] - Wedbush predicts Tesla's market value will reach $3 trillion by the end of 2026, with Full Self-Driving (FSD) penetration potentially exceeding 50% [1][8] - Analyst Dan Ives states that Tesla is advancing towards an "AI revolution," with autonomous driving and robotics as core focus areas by 2026 [1][8] Group 2: Nvidia - Nvidia's stock increased by 0.73%, with a trading volume of $28.936 billion [1][10] - The company announced the launch of its new flagship open-source model series, Nemotron 3, which boasts improvements in speed, cost-effectiveness, and intelligence [1][10] Group 3: Broadcom - Broadcom's stock fell by 5.59%, with a trading volume of $22.525 billion, marking a three-day cumulative decline of 17.7% [2][9] - CICC maintains an "outperform" rating for Broadcom, with a target price of $475, citing strong AI ASIC revenue and a backlog of $73 billion [2][9] - The firm has raised its earnings forecast for FY26/FY27 due to increased visibility in revenue from AI computing and networking [2][9] Group 4: Amazon and Meta Platforms - Amazon's stock declined by 1.61%, with a trading volume of $10.253 billion, marking three consecutive days of decline [3][10] - Meta Platforms' stock rose by 0.59%, with a trading volume of $9.842 billion; the company is offering up to $100 million in signing bonuses for engineers and $250 million for top AI researchers [3][10] Group 5: Oracle - Oracle's stock decreased by 2.66%, with a trading volume of $8.047 billion; the company is facing scrutiny over its aggressive AI investment strategy [3][10] - Analysts expect Oracle's bonds to remain under pressure as the company recorded its largest stock drop in nearly 11 months [3][10] Group 6: Eli Lilly - Eli Lilly's stock rose by 3.38%, with a trading volume of $4.902 billion; the approval process for its experimental oral weight-loss drug, orforglipron, is expected to accelerate [4][11] - The potential approval date may be moved up to March 2026 from mid-May 2026, enhancing Eli Lilly's competitive position in the growing weight-loss market [4][11] Group 7: ServiceNow - ServiceNow's stock fell by 11.54%, with a trading volume of $4.555 billion; the company is in advanced talks to acquire cybersecurity startup Armis for up to $7 billion [4][11] - The deal, if completed, would be ServiceNow's largest acquisition to date, although there are risks of negotiation breakdowns or competing bids [4][11] Group 8: Strategy - Strategy's stock dropped by 8.14%, with a trading volume of $4.089 billion, following a decline in Bitcoin prices [4][12] - The CEO confirmed that the company's Bitcoin accumulation strategy is ongoing and will continue through the end of 2025 [4][12]

[Chart courtesy of MarketWatch.com][Chart courtesy of MarketWatch.com]Moving the marketThe market tried to get something going early, but the bounce fizzled and the major indexes slipped back into the red as pressure in the AI space kept weighing on sentiment.Chipmaker Broadcom dropped more than 4%, while Oracle slid over 3%, extending last week’s weakness that already had the S&P 500 and Nasdaq on the back foot. For now, it’s starting to look like the “Magnificent 7” may be a little less magnificent headin ...

Why Middle-Class Retirees Still Worry Despite COLA Increases 31 minutes ago Retirees now know the Social Security COLA for next year is 2.8%. Payments reflecting the increase begin in January 2026, but the modest bump of $56 per month, on average, won't likely quell deeper concerns about the program among. Many retired workers fear that their actual costs are rising faster than the adjustment, while those still in the workforce grapple with larger fears that Social Security won't be there when they need it. ...

Core Insights - The focus is shifting from pure-play quantum computing startups to companies enabling quantum technology through classical infrastructure and secure IT environments [1][9] - The quantum computing market is projected to grow significantly, with a CAGR of 20.5% from $1.4 billion in 2024 to over $4.2 billion by 2030, while the post-quantum cryptography market is expected to grow from $0.42 billion in 2025 to $2.84 billion by 2030, at a CAGR of 46% [4] Company Summaries - **Advanced Micro Devices (AMD)**: Partnering with IBM to develop quantum-centric supercomputing architectures that integrate quantum and classical computing technologies. Expected earnings growth of 26.8% and revenue growth of 57.8% in 2026 [5][6] - **Teradyne (TER)**: Acquiring Quantifi Photonics to enhance testing capabilities for photonic integrated circuits, crucial for next-generation quantum systems. Expected earnings growth of 44.6% and revenue growth of 22% in 2026 [7][8] - **Broadcom (AVGO)**: Launched Brocade Gen 8 Fibre Channel networking platforms with quantum-safe encryption, indicating a move towards monetizing quantum-resilient security capabilities. Expected earnings growth of 34.9% and revenue growth of 34.1% in fiscal 2026 [10][11] - **Applied Materials (AMAT)**: Collaborating with Xanadu and Qolab to advance quantum hardware fabrication processes, emphasizing its role in materials engineering for quantum devices. Expected earnings growth of 1.3% and revenue growth of 2% in fiscal 2026 [12][13] - **Oracle (ORCL)**: Engaging in partnerships to provide advanced quantum-safe security solutions and launching the Oracle Defense Ecosystem to foster innovation in defense technologies. Expected earnings growth of 15.4% and revenue growth of 16.6% in fiscal 2026 [14]

Core Viewpoint - Oracle's stock has experienced volatility, swinging from irrational exuberance due to strong commitments from OpenAI to a more cautious outlook as market sentiments shift [1]. Group 1: Company Analysis - The stock of Oracle (ORCL) saw a surge in value following significant commitments from OpenAI, indicating a strong market reaction to partnerships and growth potential [1]. - The current market sentiment suggests a correction from previous highs, reflecting a more balanced view of Oracle's growth prospects [1]. Group 2: Analyst Perspective - Julian Lin, a financial analyst, emphasizes the importance of identifying undervalued companies with sustainable growth, focusing on those with robust balance sheets and effective management [1]. - Lin leads an investment group that prioritizes stocks with a high probability of outperforming the S&P 500, combining growth principles with strict valuation criteria to enhance investment safety [1].

Core Insights - Leading healthcare organizations are adopting Oracle Fusion Cloud Applications to enhance productivity, reduce costs, and improve employee and patient experiences [1][2] Group 1: Company Initiatives - Billings Clinic-Logan Health aims to streamline operations and standardize key business processes to provide quality care [3] - Children's Hospital Los Angeles seeks to unify its business systems to improve operational efficiency and patient care [5] - Regency Integrated Health Services is replacing disparate systems with an integrated suite to enhance productivity and patient experience [7] Group 2: Challenges Faced - Healthcare organizations are dealing with fluctuating patient demand, shrinking budgets, supply chain disruptions, and workforce scheduling complexities [2] - Legacy systems have created challenges that divert resources from improving patient care [4][6] Group 3: Benefits of Oracle Fusion Applications - Oracle Fusion Applications leverage embedded AI to improve insights, productivity, and employee experience, allowing healthcare organizations to focus on patient care [2][4][6] - The applications help unify processes across finance, HR, supply chain, and customer experience, enabling better operational efficiency [8][9]

In at least one corner of the artificial intelligence market, sentiment has turned decidedly negative. Broadcom, CoreWeave and Oracle, three companies intimately tied to the AI infrastructure buildout, all had another rough day on Wall Street on Monday after selling off sharply last week. While the three stocks are all still solidly up for the year — CoreWeave held its market debut in March — the most recent trend suggests that investors are concerned about whether the returns on investment will ever justif ...

Core Viewpoint - Oracle's stock experienced its worst trading day since 2001, closing 11% lower after Q2 revenues missed estimates, leading to a significant widening of its CDS spread [1][2] Financial Performance - Oracle reported total revenue of $16.1 billion for fiscal Q2 2026, a 14% increase year-over-year, although it fell short of the estimated $16.21 billion [5] - The cloud segment generated approximately $8 billion in revenue, reflecting a year-over-year growth of 34% [5] - Earnings per share for the quarter were $2.26, up 54% from the previous year, exceeding the consensus estimate of $1.64 [6] Debt and Capital Expenditure - The company has a substantial debt load exceeding $100 billion and is projected to increase its capital expenditure forecast to about $50 billion in fiscal year 2026, up from $35 billion [2] - The widening CDS spread indicates increased costs for raising debt, which could impact future fundraising efforts [1][2] Market Sentiment and Future Outlook - Despite the recent stock decline, Oracle's year-to-date performance remains positive with a nearly 12% increase, raising questions about the sustainability of its fundamentals [4] - The company's historical performance shows a mixed record in meeting earnings estimates over the past eight quarters, which may affect investor sentiment moving forward [6]

Group 1 - The article does not contain any relevant content regarding companies or industries [1][2][3][4][5][6]

Let's bring in Charlie Babrinskcoy. He's the vice chair of Aerial Investments. Charlie, it's great to see you again.Welcome. >> Thank you. Welcome back, Kelly.Great to see you. >> Thank you. And I you I one of my most memorable things right before I I think I I went out was that you had said to everybody, be careful with Oracle here.Think twice before getting involved. And that was maybe I don't know 30 40% from where we are now. So what what do you do with the stock now.Yeah, I think my exact words were tr ...